Rating History for Ernexa Therapeutics (ERNA) by Brookline Capital Markets

More Stocks Rated by Brookline Capital Markets | Latest Ratings for ERNA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/7/2026 N/A New Coverage Buy
(N/A)		 30.00
(N/A)		 6.04
(5.54)		 -8.28% Details